We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Smart Nanoparticles Deliver Selective Heating to Kill Tumors

By LabMedica International staff writers
Posted on 28 Jul 2016
Print article
Image: A team of scientists has discovered an organic ‘smart’ biodegradable nanoparticle, named PEARL, that uses light and heat in a controlled manner to target and destroy tumors with bigger precision (Photo courtesy of the University Health Network).
Image: A team of scientists has discovered an organic ‘smart’ biodegradable nanoparticle, named PEARL, that uses light and heat in a controlled manner to target and destroy tumors with bigger precision (Photo courtesy of the University Health Network).
Cancer researchers have demonstrated a novel type of "smart" nanoparticle that can destroy a tumor through selective heating while causing minimal damage to surrounding normal tissues.

Investigators at University Health Network (Toronto, Canada) described the use of PEARLs (photo-thermal enhancing auto-regulating liposomes) in a proof-of-concept paper that was published in the July 14, 2016, online edition of the journal Angewandte Chemie.

Photothermal therapy (PTT) is enhanced by the use of nanoparticles with a large optical absorption at the treatment wavelength. However, this comes at the cost of higher light attenuation that results in reduced depth of heating as well as larger thermal gradients, leading to potential over- and under-treatment in the target tissue. These limitations can be overcome by using PEARLs, which are based on thermochromic J-aggregate forming dye–lipid conjugates that reversibly alter their absorption above a predefined lipid phase-transition temperature.

The investigators showed - in nanoparticle solutions and in gel phantoms containing the nanoparticles - that under irradiation by near-infrared light, deeper layers of the target tissue reverted to the intrinsic optical absorption, halting the temperature rise and enabling greater light penetration and heat generation at depth.

Senior author Dr. Gang Zheng, professor of medical biophysics at the University Health Network, said, "Our smart nanoparticle is super cool. It can absorb light, generate heat, and ablate the tumor. It is a thermal sensor and once it reaches the desired ablation temperature of 55 degrees Celsius, it becomes invisible allowing the light to move deeper into more areas of tumor and repeat the treatment process. The result is a promising new way to heat and ablate larger volumes of tumor with minimal damage to surrounding tissues in a controlled and precise way. The next step is to conduct pre-clinical studies to test the concept further."

Related Links:
University Health Network


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Sekisui Diagnostics UK Ltd.